Benzodiazepine Exposure in Pregnancy Does Not Up Risk for ADHD, Autism

WEDNESDAY, Nov. 30, 2022 (HealthDay News) -- Benzodiazepine exposure during pregnancy seems not to be associated with increased risks for development of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), according to a study published online Nov. 22 in JAMA Network Open.
Vincent Chin-Hung Chen, M.D., from Chiayi Chang Gung Memorial Hospital in Chiayi, Taiwan, and colleagues conducted a cohort study to examine whether prenatal benzodiazepine exposure is associated with development of ASD and ADHD. Data were included for 1,138,732 mothers with 1,516,846 live births between Jan. 1, 2004, and Dec. 31, 2017.
Overall, 5.0 percent of the children were exposed to a benzodiazepine during pregnancy. The researchers found that benzodiazepine exposure was associated with increased risks for ADHD (hazard ratios [95 percent confidence intervals], 1.24 [1.20 to 1.28], 1.27 [1.21 to 1.34], and 1.25 [1.14 to 1.37] for first-, second-, and third-trimester exposure, respectively) and ASD (hazard ratios [95 percent confidence intervals], 1.13 [1.05 to 1.21], 1.10 [0.98 to 1.22], and 1.21 [1.00 to 1.47] for first-, second-, and third-trimester exposure, respectively). However, compared with unexposed sibling controls during the same period, the differences were no longer significant for ADHD (hazard ratios [95 percent confidence intervals], 0.91 [0.83 to 1.00], 0.89 [0.78 to 1.01], and 1.08 [0.83 to 1.41] for first-, second-, and third-trimester exposure, respectively) or ASD (hazard ratios [95 percent confidence intervals], 0.92 [0.75 to 1.14], 0.97 [0.71 to 1.33], and 1.07 [0.53 to 2.16] for first-, second-, and third-trimester exposure, respectively).
"Our results challenge current assumptions of a potential association of neurodevelopmental disorders with maternal benzodiazepine use before or during pregnancy," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Related Posts
Diabetes Tied to Higher Use of Hospital Bed-Days for Many Conditions
MONDAY, Aug. 7, 2023 (HealthDay News) -- Type 2 diabetes is associated with...
Review Explores Telehealth for Substance Use Disorders
TUESDAY, March 22, 2022 (HealthDay News) -- The use of telehealth for the...
Los ‘fans tóxicos’: cuando la adoración de su hijo por un famoso llega demasiado lejos
JUEVES, 13 de abril de 2023 (HealthDay News) -- No es nada nuevo que los jóvenes...
AHA News: On a Snowy Day, the Warmth of a Stranger Kept One Man Alive
TUESDAY, April 18, 2023 (American Heart Association News) -- In the early months...